American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$280M |
| 2 |
Kenvue
KVUE
|
+$272M |
| 3 |
Norfolk Southern
NSC
|
+$240M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$234M |
| 5 |
Amazon
AMZN
|
+$183M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$251M |
| 2 |
Walt Disney
DIS
|
+$204M |
| 3 |
Advanced Micro Devices
AMD
|
+$174M |
| 4 |
MarketAxess Holdings
MKTX
|
+$168M |
| 5 |
Johnson & Johnson
JNJ
|
+$162M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.02% |
| 2 | Healthcare | 13.44% |
| 3 | Financials | 13.33% |
| 4 | Consumer Discretionary | 11.78% |
| 5 | Industrials | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Chegg
CHGG
$86.3M
| $186K | ﹤0.01% |
20,847
+5,786
| +38% | +$56.4K |
|
2577
Tarsus Pharmaceuticals
TARS
$3.03B
| $185K | ﹤0.01% |
10,427
-793
| -7% | -$14K |
|
2578
ThredUp
TDUP
$412M
| $182K | ﹤0.01% |
45,355
+15,644
| +53% | +$53.1K |
|
2579
Caribou Biosciences
CRBU
$165M
| $181K | ﹤0.01% |
37,802
+10,374
| +38% | +$64.4K |
|
2580
Alto Ingredients
ALTO
$327M
| $180K | ﹤0.01% |
40,726
+20,640
| +103% | +$79.7K |
|
2581
Concrete Pumping Holdings
BBCP
$477M
| $179K | ﹤0.01% |
+20,848
| New | +$168K |
|
2582
Lyell Immunopharma
LYEL
$344M
| $178K | ﹤0.01% |
6,048
+2,042
| +51% | +$97K |
|
|
SRG
2583
Seritage Growth Properties
SRG
$130M
| $178K | ﹤0.01% |
22,970
+8,612
| +60% | +$72.2K |
|
2584
PMV Pharmaceuticals
PMVP
$66.1M
| $177K | ﹤0.01% |
28,811
+8,146
| +39% | +$56K |
|
2585
Allogene Therapeutics
ALLO
$704M
| $176K | ﹤0.01% |
55,536
+12,380
| +29% | +$54.3K |
|
2586
Bit Digital
BTBT
$523M
| $174K | ﹤0.01% |
+81,534
| New | +$256K |
|
2587
Liberty Latin America Class A
LILA
$1.67B
| $170K | ﹤0.01% |
30,672
+8,583
| +39% | +$49.8K |
|
2588
Petco
WOOF
$814M
| $169K | ﹤0.01% |
41,381
+20,080
| +94% | +$132K |
|
2589
TaskUs
TASK
$650M
| $169K | ﹤0.01% |
16,290
+3,964
| +32% | +$42.6K |
|
2590
Atea Pharmaceuticals
AVIR
$417M
| $168K | ﹤0.01% |
55,893
+21,503
| +63% | +$73.2K |
|
2591
Fulcrum Therapeutics
FULC
$283M
| $164K | ﹤0.01% |
36,939
+8,522
| +30% | +$37.2K |
|
|
SPR
2592
DELISTED
Spirit AeroSystems
SPR
| $163K | ﹤0.01% |
10,129
| – | – |
|
2593
Limoneira
LMNR
$253M
| $163K | ﹤0.01% |
+10,664
| New | +$163K |
|
|
SFIX
2594
Stitch Fix
SFIX
$482M
| $162K | ﹤0.01% |
46,929
+12,417
| +36% | +$49.6K |
|
2595
Zegna
ZGN
$3.74B
| $159K | ﹤0.01% |
11,413
-9
| -0.1% | -$131 |
|
|
CNSL
2596
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $158K | ﹤0.01% |
46,277
+16,488
| +55% | +$60.6K |
|
2597
Lifetime Brands
LCUT
$221M
| $158K | ﹤0.01% |
+28,094
| New | +$170K |
|
2598
SiriusXM
SIRI
$9.47B
| $158K | ﹤0.01% |
3,494
+479
| +16% | +$22.3K |
|
2599
Adtran
ADTN
$666M
| $157K | ﹤0.01% |
19,123
+4,673
| +32% | +$41.5K |
|
|
BLFY
2600
DELISTED
Blue Foundry Bancorp
BLFY
| $155K | ﹤0.01% |
18,529
+3,431
| +23% | +$32.6K |
|
Similar funds
American Century Companies's Q3 2023 Portfolio in Review
As of Q3 2023, American Century Companies held 2,931 positions worth $130B, down 2.3% from $133B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
American Century Companies's Q3 2023 filing shows 141 new, 1,882 increased, 655 reduced and 91 closed positions. Its largest new stake was Seadrill: 2,264,354 shares worth $101M. The largest sale was Marvell Technology, an estimated $251M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- American Century Companies's largest Q3 2023 buy was Seadrill: 2,264,354 shares worth $101M.
- American Century Companies added most to NVIDIA in Q3 2023, an estimated $280M increase.
- American Century Companies's biggest Q3 2023 reduction was Marvell Technology, cutting an estimated $251M.
- American Century Companies fully exited AngloGold Ashanti in Q3 2023, selling an estimated $39.7M.
- American Century Companies's ten largest holdings make up 23% of its $130B portfolio in Q3 2023.
- American Century Companies opened 141 new positions and closed 91 in Q3 2023.
- American Century Companies's portfolio value fell 2.3% quarter-over-quarter to $130B.
Based on American Century Companies's 13F filing for Q3 2023, filed 13 Nov 2023.